Dr. Navile Aditya Murali provides comprehensive medical oncology care for patients with solid tumors and hematological malignancies. Treatment plans are tailored according to cancer type, stage, overall health and individual clinical requirements.
He provides chemotherapy for selected solid tumors and blood cancers using evidence-based treatment protocols. The treatment plan is determined according to the cancer diagnosis, stage and overall condition of the patient.
Dr. Murali provides immunotherapy for suitable cancer patients where clinically indicated. Immunotherapy works by enhancing or modifying the immune system's ability to identify and attack cancer cells.
Targeted therapies may be used for cancers that have specific molecular or genetic characteristics. Treatment selection is based on the cancer type, pathology and appropriate diagnostic findings.
Dr. Murali has a special clinical interest in lung cancer management and provides systemic therapies such as chemotherapy, immunotherapy and other appropriate medical oncology treatments depending on the type and stage of lung cancer.
He evaluates and manages different hematological malignancies including leukemia. Treatment may involve chemotherapy, supportive therapy and advanced hematology-oncology treatment strategies based on the specific leukemia subtype.
Dr. Murali provides treatment for different types of lymphoma using systemic therapy and other advanced oncology approaches tailored to the type and stage of the disease.
He has expertise in the management of multiple myeloma, including systemic therapies, high-dose chemotherapy and autologous stem cell transplantation for selected patients.
Dr. Murali is experienced in comprehensive bone marrow transplant programs for selected patients with blood cancers and other hematological conditions requiring advanced transplant-based treatment.
Autologous transplantation involves collecting and later returning a patient's own stem cells following high-dose treatment. Dr. Murali has expertise in this approach for selected hematological malignancies.
High-dose chemotherapy may be used as part of advanced treatment strategies for selected cancers, particularly in conjunction with autologous transplantation when clinically appropriate.
Dr. Murali has specialised exposure to cellular therapy through advanced training and observership experience. Cellular treatment approaches may be considered for selected hematological malignancies based on clinical indications.
He manages complications associated with cancer treatment, including infections and other treatment-related concerns that can arise during intensive chemotherapy.
Dr. Murali provides systemic medical oncology treatment for a variety of solid tumors using chemotherapy, immunotherapy, targeted therapy and other appropriate cancer treatments.